Home / Stocks / KTTA

KTTA insider trading

Pasithea Therapeutics Corp. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
4
Bought · 24 mo
$203k
Buys · last 90 days
1 · $53k
Most recent buy
2026-06-22

Cluster buy detected

3 insiders bought KTTA within a short window (2025-11-28), $150k in total — cluster score 29/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-06-22Coastlands Capital LP
10% owner
Bought100,000$0.53$53k
2025-12-01STEINMAN LAWRENCEcluster
Director
Bought133,333$0.75$100k
2025-12-01Marques Tiagocluster
Chief Executive Officer
Bought33,333$0.75$25k
2025-12-01Dumesnil Simoncluster
Director
Bought33,333$0.75$25k

Most active insider buyers

InsiderRoleBuysTotal bought
STEINMAN LAWRENCEDirector1$100k
Coastlands Capital LP10% owner1$53k
Marques TiagoChief Executive Officer1$25k
Dumesnil SimonDirector1$25k

See KTTA on the chart

Every insider buy and sell for KTTA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.